A new technology from the University of Minnesota has resulted in a startup that may help prolong the lives of victims suffering from massive blood loss or trauma. The university's Office for Technology Commercialization ...
Oct 18, 2011
1
0
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other ...
Sep 22, 2011
0
0
(AP) -- New Jersey officials have revoked the medical license of an oncologist they say committed "gross and repeated acts of negligence" that led to an outbreak of hepatitis B among his patients.
Sep 15, 2011
0
0
